The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

Emerging Treatments for Social Disconnection in Psychiatric Illness

New York, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Emerging Treatments for Social Disconnection in Psychiatric Illness” on Tuesday, March 11, 2025, at 2:00 pm ET.

Register Now to explore groundbreaking research on the mental health issue: social disconnection.

Defined as social isolation and loneliness, social disconnection is a major health comparable to smoking, according to the National Institutes of Health. Social disconnection is widespread in psychiatric illness, and social dysfunction is a symptom that spans the spectrum of psychiatric diagnoses. Despite its significant impact, no pharmacologic treatments are currently available to improve social connection. However, promising new research in the field of social psychopharmacology is exploring innovative ways to address this gap.

In this webinar, Anya Bershad M.D., PhD., Assistant Professor in the Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior at UCLA, will discuss her latest findings on how pharmacologic compounds could improve social connection in psychiatric illness.

The session will be hosted by Jeffrey Borenstein, M.D., President & CEO of the Brain & Behavior Research Foundation and host of the Emmy® nominated television series Healthy Minds.

About Brain & Behavior Research Foundation
The Brain & Behavior Research Foundation (BBRF) awards research grants to develop improved treatments, cures, and methods of prevention for mental illness. These illnesses include addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, and schizophrenia, as well as research on suicide prevention. Since 1987, the Foundation has awarded more than $462 million to fund more than 5,600 leading scientists around the world. 100% of every dollar donated for research is invested in research. BBRF operating expenses are covered by separate foundation grants. BBRF is the producer of the Emmy® nominated public television series Healthy Minds with Dr. Jeffrey Borenstein, which aims to remove the stigma of mental illness and demonstrate that with help, there is hope.

Attachments


Myrna Manners
Brain & Behavior Research Foundation
(718) 986-7255
mmanners@mannersdotson.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.